SOURCE: NICOX

May 10, 2006 13:23 ET

NicOx to Present at the Rodman & Renshaw 3rd Annual Global Healthcare conference

Sophia Antipolis Cedex -- (MARKET WIRE) -- May 10, 2006 -- May 10, 2006. Sophia Antipolis, France. www.nicox.com

NicOx S.A. (Eurolist: NICOX) today announced that it will present at the Rodman & Renshaw 3rd Annual Global Healthcare conference at 2:40 pm CET (1:40 pm UK - 8:40 am US Eastern time) on Tuesday May 16, 2006 at The Le Meridien Beach Plaza Hotel, Monte Carlo, Monaco.

Michele Garufi, Chairman and Chief Executive Officer of NicOx, will provide an update on the Company's corporate and development progress.

No live audio broadcast or archived recording will be available. The presentation will be posted on NicOx' website http://www.nicox.com.

NicOx S.A. (Bloomberg: COX:FP, Reuters: NCOX.LN) is a product-driven biopharmaceutical company dedicated to the development of nitric oxide-donating drugs to meet unmet medical needs. NicOx is targeting the therapeutic areas of inflammatory and cardio-metabolic diseases. Resources are focused on two lead compounds, HCT 3012, in phase 3 development for the treatment of osteoarthritis, and NCX 4016, in phase 2 for Peripheral Arterial Obstructive Disease (PAOD). NicOx has strategic partnerships with some of the world's leading pharmaceutical companies, including Pfizer Inc. and Merck and Co., Inc.

NicOx S.A. is headquartered in Sophia-Antipolis, France, and is a public company listed on the Eurolist of Euronext Paris (segment: Next Economy).

The elements included in this communication may contain forward looking statements subject to certain risks and uncertainties. Actual results of the company may differ materially from those indicated in the forward-looking statements because of different risks factors described in the company's document de reference.

CONTACTS:

NicOx: Karl Hanks - Manager of Corporate Relations and Market Analysis - Tel +33 (0)4 97 15 22 03 - hanks@nicox.com - www.nicox.com

Investors in the United States - Burns McClellan: Lisa Burns - lburns@burnsmc.com / Laura Siino - lsiino@burnsmc.com - Tel +1 212 213 0006

Financial Dynamics: Jonathan Birt - Tel +1 212 850 56 34 - jbirt@fd-us.com / Julia Phillips - Tel +44 (0)20 7831 3113 - julia.phillips@fd.com

NicOx S.A.,

2455 route des Dolines, Espace Gaïa II, BP313, 06906 Sophia Antipolis cedex, France. Tel. +33 (0)4 9238 7020 - Fax +33 (0)4 9238 7030

This information is provided by CompanynewsGroup

Contact Information